Asia Pacific trial sector poised for continued growth, says Novotech

By Gareth Macdonald

- Last updated on GMT

Related tags: Asia pacific, Contract research organization, United states

Asia Pacific trial sector poised for continued growth, says Novotech
The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.

Safarian told Outsourcing-pharma there had been a four-fold increase in trials being conducted by contract research organisations (CRO) in a number of countries in Asia Pacific, with India, Taiwan and Novotech’s base, Australia, seeing the biggest gains.

He also predicted that, while in common with other developing clinical trial hubs like Latin America and Central and Eastern Europe (CEE) the Asia Pacific market will continue to expand, the three billion potential patients in the region make it a unique opportunity for sponsors.

Safarian also suggested that factors like Asia Pacific's ethnic diversity and its reverse seasonality, with respect to the Northern hemisphere, are becoming increasingly attractive to global pharmaceutical firms keen to tap emerging pharmaceutical markets.

Related news

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars